469 related articles for article (PubMed ID: 28332014)
1. Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with high-grade glioma, a systematic review and meta-analysis.
van Dijken BRJ; van Laar PJ; Holtman GA; van der Hoorn A
Eur Radiol; 2017 Oct; 27(10):4129-4144. PubMed ID: 28332014
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of proton magnetic resonance spectroscopy and perfusion-weighted imaging in brain gliomas follow-up: a single institutional experience.
Anselmi M; Catalucci A; Felli V; Vellucci V; Di Sibio A; Gravina GL; Di Staso M; Di Cesare E; Masciocchi C
Neuroradiol J; 2017 Jun; 30(3):240-252. PubMed ID: 28627984
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of MRI techniques for treatment response evaluation in patients with brain metastasis: A systematic review and meta-analysis.
Teunissen WHT; Govaerts CW; Kramer MCA; Labrecque JA; Smits M; Dirven L; van der Hoorn A
Radiother Oncol; 2022 Dec; 177():121-133. PubMed ID: 36377093
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of dynamic contrast-enhanced perfusion MRI in stratifying gliomas: A systematic review and meta-analysis.
Okuchi S; Rojas-Garcia A; Ulyte A; Lopez I; Ušinskienė J; Lewis M; Hassanein SM; Sanverdi E; Golay X; Thust S; Panovska-Griffiths J; Bisdas S
Cancer Med; 2019 Sep; 8(12):5564-5573. PubMed ID: 31389669
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis.
Wang Q; Zhang H; Zhang J; Wu C; Zhu W; Li F; Chen X; Xu B
Eur Radiol; 2016 Aug; 26(8):2670-84. PubMed ID: 26471274
[TBL] [Abstract][Full Text] [Related]
6. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
7. Perfusion MRI as a diagnostic biomarker for differentiating glioma from brain metastasis: a systematic review and meta-analysis.
Suh CH; Kim HS; Jung SC; Choi CG; Kim SJ
Eur Radiol; 2018 Sep; 28(9):3819-3831. PubMed ID: 29619517
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Values of DCE-MRI and DSC-MRI for Differentiation Between High-grade and Low-grade Gliomas: A Comprehensive Meta-analysis.
Liang J; Liu D; Gao P; Zhang D; Chen H; Shi C; Luo L
Acad Radiol; 2018 Mar; 25(3):338-348. PubMed ID: 29223713
[TBL] [Abstract][Full Text] [Related]
9. Amide proton transfer-weighted MRI in distinguishing high- and low-grade gliomas: a systematic review and meta-analysis.
Suh CH; Park JE; Jung SC; Choi CG; Kim SJ; Kim HS
Neuroradiology; 2019 May; 61(5):525-534. PubMed ID: 30666352
[TBL] [Abstract][Full Text] [Related]
10. Spatial distribution of malignant tissue in gliomas: correlations of 11C-L-methionine positron emission tomography and perfusion- and diffusion-weighted magnetic resonance imaging.
Tietze A; Boldsen JK; Mouridsen K; Ribe L; Dyve S; Cortnum S; Østergaard L; Borghammer P
Acta Radiol; 2015 Sep; 56(9):1135-44. PubMed ID: 25270372
[TBL] [Abstract][Full Text] [Related]
11. Comparison of unsupervised classification methods for brain tumor segmentation using multi-parametric MRI.
Sauwen N; Acou M; Van Cauter S; Sima DM; Veraart J; Maes F; Himmelreich U; Achten E; Van Huffel S
Neuroimage Clin; 2016; 12():753-764. PubMed ID: 27812502
[TBL] [Abstract][Full Text] [Related]
12. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
[TBL] [Abstract][Full Text] [Related]
13. Role of magnetic resonance spectroscopy to differentiate high-grade gliomas from metastases.
Wang Q; Zhang J; Xu W; Chen X; Zhang J; Xu B
Tumour Biol; 2017 Jun; 39(6):1010428317710030. PubMed ID: 28631566
[TBL] [Abstract][Full Text] [Related]
14. Dynamic Contrast-Enhanced Perfusion MRI and Diffusion-Weighted Imaging in Grading of Gliomas.
Arevalo-Perez J; Peck KK; Young RJ; Holodny AI; Karimi S; Lyo JK
J Neuroimaging; 2015; 25(5):792-8. PubMed ID: 25867683
[TBL] [Abstract][Full Text] [Related]
15. Comparison between magnetic resonance spectroscopy and diffusion weighted imaging in the evaluation of gliomas response after treatment.
Lotumolo A; Caivano R; Rabasco P; Iannelli G; Villonio A; D' Antuono F; Gioioso M; Zandolino A; Macarini L; Guglielmi G; Cammarota A
Eur J Radiol; 2015 Dec; 84(12):2597-604. PubMed ID: 26391231
[TBL] [Abstract][Full Text] [Related]
16. Added value of advanced over conventional magnetic resonance imaging in grading gliomas and other primary brain tumors.
Guzmán-De-Villoria JA; Mateos-Pérez JM; Fernández-García P; Castro E; Desco M
Cancer Imaging; 2014 Dec; 14(1):35. PubMed ID: 25608821
[TBL] [Abstract][Full Text] [Related]
17. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with head and neck tumors, a systematic review and meta-analysis.
van der Hoorn A; van Laar PJ; Holtman GA; Westerlaan HE
PLoS One; 2017; 12(5):e0177986. PubMed ID: 28542474
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Accuracy of Neuroimaging to Delineate Diffuse Gliomas within the Brain: A Meta-Analysis.
Verburg N; Hoefnagels FWA; Barkhof F; Boellaard R; Goldman S; Guo J; Heimans JJ; Hoekstra OS; Jain R; Kinoshita M; Pouwels PJW; Price SJ; Reijneveld JC; Stadlbauer A; Vandertop WP; Wesseling P; Zwinderman AH; De Witt Hamer PC
AJNR Am J Neuroradiol; 2017 Oct; 38(10):1884-1891. PubMed ID: 28882867
[TBL] [Abstract][Full Text] [Related]
20. MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta-analysis.
Suh CH; Kim HS; Jung SC; Park JE; Choi CG; Kim SJ
J Magn Reson Imaging; 2019 Aug; 50(2):560-572. PubMed ID: 30637843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]